Patent · US Active

Immune modulating oligonucleotides in connection with chemotherapeutic measures

US9212366B2 · kind B2 · utility

9Cited by

2References

8Claims

0Family size

Assignee

Mologen AG · DE

Inventors

Burghardt Wittig · Berlin, DE
Manuel Schmidt · Berlin, DE
Heribert Bohlen · Cologne, DE

Key dates

Filing date	Aug 9, 2005
Grant date	Dec 15, 2015
Priority date	—
Expiry date	Aug 28, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of immune modulators on the basis of DNA in the form of covalently closed nucleic acid molecules comprising immune stimulatory sequence motifs, for the production of a pharmaceutical for the therapeutic treatment of tumor diseases in combination with chemotherapeutic drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.